Search results for "neuropathy"

showing 10 items of 213 documents

Familial Amyloid Polyneuropathy

2013

Familial amyloid polyneuropathy (FAP; also known as familiar amyloidosis and hereditary amyloidosis) is an autosomal dominant inherited disease due to mutations of the transthyretin (TTR) gene coding for the corresponding protein, consisting of 127 amino acids. The gene is located on chromosome 18q. More than 100 different mutations are known. Other mutant precursor proteins produced in the liver, such as apolipoprotein I and II, lysozyme and fibrinogen Aα, may be of etiological importance as well. Amyloidogenic mutations of the TTR gene lead to decreased stability of the corresponding protein and subsequently to extracellular deposition of amyloid in several tissues (peripheral and autonom…

Amyloid Neuropathies Familialmedicine.medical_specialtyAmyloidbiologyApolipoprotein Bbusiness.industrymedicine.medical_treatmentAmyloidosisGastroenterologyGeneral MedicineDiseaseLiver transplantationmedicine.diseaseGastroenterologyLiver TransplantationTransthyretinAmyloid NeuropathyInternal medicinePrevalencebiology.proteinmedicineHumansPrealbuminbusinessPolyneuropathyDigestive Diseases
researchProduct

251 SENSORY PROFILES IN PAINFUL VS. NON-PAINFUL CHEMOTHERAPY-INDUCED POLYNEUROPATHY

2007

Anesthesiology and Pain MedicineChemotherapy inducedbusiness.industryAnesthesiaMedicineSensory systembusinessmedicine.diseasePolyneuropathyEuropean Journal of Pain
researchProduct

Uveal effusion syndrome complicated by anterior ischemic optic neuropathy

1995

We report on a case of idiopathic uveal effusion syndrome complicated by AION. To our knowledge such an association hasn't been previously described. We suggest that scleral thickening caused obstruction of vortex veins followed by uveal effusion and compression of posterior ciliary arteries within their intrascleral tract, leading to AION. Nevertheless it can't be excluded that AION was the result of mechanical compression on ciliary vessels of optic disc by choroidal detachment. © 1996, Kluwer Academic Publishers. All rights reserved.

AtropineMydriaticsmedicine.medical_specialtyFundus OculiAnti-Inflammatory AgentsVisual AcuityIdiopathic uveal effusion syndromeDexamethasoneOptic neuropathyPregnenedionesPhysiology (medical)Ophthalmologymedicine.arteryHumansMedicineOptic Neuropathy IschemicFluorescein Angiographymedicine.diagnostic_testbusiness.industrySettore MED/30 - Malattie Apparato VisivoCiliary BodyRetinal DetachmentChoroid DiseasesSyndromeUveal DiseasesMiddle AgedFluorescein angiographymedicine.diseaseeye diseasesSensory SystemsScleral thickeningCiliary arteriesSurgeryOphthalmologyAnterior ischemic optic neuropathymedicine.anatomical_structureEffusionOptic nerveAnterior ischemic optic neuropathyFemalesense organsOphthalmic SolutionsbusinessOptic disc
researchProduct

Hyperbilirubinemia, Auditory Neuropathy and Prelingually Deafness: Evidence Linking

2013

Auditory neuropathy
researchProduct

Glucose regulation and pain in older people-The Helsinki Birth Cohort Study

2021

Aims: To assess if individuals with diabetes or prediabetes report more pain or have increased use of pain medication compared to normoglycaemic individuals. Methods: Using cross-sectional data, we studied 928 men and 1075 women from the Helsinki Birth Cohort Study in 2001-2004 at a mean age of 61.5 years. Glucose regulation was assessed with a 2-h 75 g oral glucose tolerance test, and applying World Health Organization criteria, participants were defined as having normoglycaemia, prediabetes (impaired fasting glucose or impaired glucose tolerance), newly diagnosed diabetes or previously diagnosed diabetes. Self-reported pain intensity and interference during the previous 4 weeks was estima…

Blood GlucoseMalePREDICTOREpidemiologyIMPACTEndocrinology Diabetes and MetabolismglukoosiaineenvaihduntaprediabetesDISEASECohort StudiesImpaired glucose tolerance0302 clinical medicinepain030212 general & internal medicinePrediabetesepidemiologiaPOPULATION2. Zero hungereducation.field_of_studyNutrition and DieteticsdiabetesDiabetesMiddle Aged3. Good healthPREVALENCEFemaleepidemiologyFamily Practiceikääntyneetmedicine.medical_specialtyPopulationPain030209 endocrinology & metabolismPrediabetic State03 medical and health sciencesInternal medicineDiabetes mellitusGlucose IntoleranceInternal MedicinemedicineHumansTOLERANCEeducationAgedbusiness.industryBeck Depression Inventorykipumedicine.diseaseImpaired fasting glucoseLIFEHIGH-RISKCross-Sectional StudiesGlucose3121 General medicine internal medicine and other clinical medicinekrooninen kipuBlood sugar regulationbusinessBody mass indexPrediabetesPERIPHERAL NEUROPATHY
researchProduct

Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.

1998

Oxidative stress has been related to the development of diabetic neuropathy. Experimental diabetes (alloxan injection to mice) promotes early biochemical changes in peripheral nervous tissue, e.g., decrease in Na,K-ATPase activity and glutathione (GSH) peroxidase (GSHPx) activity. The former decrease can be reverted by inhibiting protein kinase C (PKC), since it has been reported that PKC is activated in these experimental conditions. Here we present data demonstrating that the inhibition of PKC, as early as 4 days after alloxan administration, is not able to return to normal values GSHPx activity in sciatic nerve of diabetic mice. Thus, it would fit with our previous proposal of the possib…

Blood GlucoseMalemedicine.medical_specialtyDiabetic neuropathyClinical BiochemistryNaphthalenesmedicine.disease_causeBiochemistryDiabetes Mellitus Experimentalchemistry.chemical_compoundMiceDiabetic NeuropathiesGlycationInternal medicineAlloxanmedicineAnimalsEnzyme InhibitorsProtein kinase CProtein Kinase CGlutathione Peroxidasebusiness.industryNervous tissueGeneral MedicineGlutathionemedicine.diseaseSciatic NerveOxidative Stressmedicine.anatomical_structureEndocrinologychemistryMolecular MedicineSciatic nerveSodium-Potassium-Exchanging ATPasebusinessOxidative stressBioFactors (Oxford, England)
researchProduct

Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels.

1993

The effect of alloxan-induced diabetes on glutathione peroxidase (GSH-Px) activity in sciatic nerve of mice has been studied. We have found, 7 days after alloxan treatment, a significant decrease in this enzymatic activity in the cytosol of sciatic nerve of diabetic mice, and moreover, that these changes remained unaltered up to 21 days after alloxan injection. No modification in the glutathione content of sciatic nerve of diabetic mice was observed throughout the experiment when compared with controls. The decrease in GSH-Px activity in this tissue shows a good correlation with the increase of blood glucose levels throughout the experiment. It is hypothesized whether a combination of mecha…

Blood GlucoseMalemedicine.medical_specialtyDiabetic neuropathyFree RadicalsRatónBiochemistryDiabetes Mellitus ExperimentalCellular and Molecular Neurosciencechemistry.chemical_compoundMiceCytosolInternal medicineDiabetes mellitusAlloxanmedicineAnimalschemistry.chemical_classificationGlutathione PeroxidaseChemistryGlutathione peroxidaseGeneral MedicineGlutathionemedicine.diseaseSciatic NervePeripheral neuropathyEndocrinologySciatic nerveSodium-Potassium-Exchanging ATPaseNeurochemical research
researchProduct

Marklose nervenfasern im Senium und im Sp�tstadium der Thalidomid-Polyneuropathie: quantitativ-elektronenmikroskopische Untersuchungen

1977

Sural nerve biopsies of four patients, aged 54–76 years, with a predominantly sensory type of neuropathy following high dosages of thalidomide were examined by light and electron microscopy. The present study includes a qualitative and quantitative evaluation of unmyelinated nerve fibers. Despite severe neuropathy, increased numbers of small unmyelinated axons per endoncurial area were noted in all patients. This numerical increase appeared to be independent of aging, since it was not seen in two senile controls, studied at the age of 83 and 88 years. The increase in the endoneurial density of unmyelinated axons, especially of small sized fibers, is likely to be related to regeneration foll…

Cellular and Molecular Neurosciencenervous systembusiness.industryUnmyelinated nerve fiberSensory neuropathyMedicineSural nerveNeurology (clinical)Degeneration (medical)AnatomybusinessPathology and Forensic MedicineActa Neuropathologica
researchProduct

Ozone Therapy as treatment for severe cases without good evolution in ophthalmology [abstract]

2019

PURPOSE: In ophthalmology many diseases lead to irreversible blindness, something that implies millions of dollars in care because people with these difficulties loose their autonomy, becoming dependent in all their everyday activities.
 This presentation will focus on clinical cases of the following pathologies treated with Ozone Therapy because all these were already being treated in a conventional way without signs of improvement. They are primary open-angle glaucoma, age-related macular degeneration, diabetic retinopathy, occlusion of the central retinal artery, facial paralysis and herpetic polyneuropathy associated with orbital apex syndrome.
 
 CASE PRESENTATION: As an…

Central retinal arterymedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryGlaucomaDiabetic retinopathyMacular degenerationmedicine.diseaseOzone therapyeye diseasesFacial paralysismedicine.arteryOphthalmologyMedicinemedicine.symptombusinessPolyneuropathyJournal of Ozone Therapy
researchProduct

Onkoloģiskās ķīmijterapijas izraisītas neiroloģiskās blakusparādības, to atkarība no pacienta dzīvildzes prognostiskajiem rādītājiem, ĶMI, dzimuma un…

2017

Virsrakst: Onkoloģiskās ķīmijterapijas izraisītas neiroloģiskās blakusparādības, to atkarība no pacienta dzīvildzes prognostiskajiem rādītājiem, ĶMI, dzimuma un ķīmijterapijas veida, iespēja blaknes mazināt. Priekšvēsture: Neiroloģiskās blakusparādības ir samērā biežas un nopietnas ķīmijterapijas blaknes. Ķīmijterapija var izraisīt pastāvīgus nopietnus bojājumus nervu sistēmā, ko reizumis nākas novērst, pārtraucot ķīmijterapiju. Neiroloģiskās blaknes bieži paliek neievērotas, atšķirībā no citām vieglāk pamanāmām. Agrīna iejaukšanās varētu mazināt neiroloģiskās blaknes, tas palīdzētu veikt pilnvērtīgu ķīmijterapijas kursu un labāk ārstēt vēzi. Mērķis: Mērķis ir noskaidrot, vai vēža pacienta …

Chemotherapy induced peripheral neuropathy (CIPN)Quality of life (QoL)Chemotherapy induced nausea and vomiting (CINV)Body mass index (BMI)MedicīnaPlatinum chemotherapy
researchProduct